Exploring Sex Differences in AD Pathogenesis Using 3-D Human Non-Cell-Autonomous Models


Alzheimer’s disease is twice more common in women than men. Moreover, women experience faster age-related cognitive decline than men. However, the precise reasons behind these differences in Alzheimer’s disease between women and men are unknown. In this application, we will explore the differential impact of sex on AD pathogenesis. We will employ two emerging technologies to quantify pathological sex-dependent changes in neurons during AD in relevant in vitro models. In preliminary work, these models have been validated to recapitulate the key pathogenic cascades of AD in normal human neurons. This proposal will address the urgent need to address the gap in knowledge of understanding the role of sex differences in AD. Ultimately, it will lead to new insights into AD pathogenesis, which ultimately will result in better interventions to prevent, monitor and treat AD.

Funding to Date



Foundational, Genetic Risk Factors


Doo Yeon Kim, Ph.D.

Daniel Irimia, M.D., Ph.D.

Related Content:

Systematic Assessment of Tandem Repeats in Alzheimer’s Disease (STaR-AD) Lars Bertram Valerija Dobricic 2024-02-28 Interpreting Alzheimer’s Disease-Associated Genetic Variation at Enhancer Regions Andreas R. Pfenning 2024-02-01 Moving the Cure Alzheimer’s Fund Genome Project Beyond Simple Associations: Integrating Functional Information, Fine-Mapping and Causal Inference Approaches into the Family-Based Analysis of the Cure Alzheimer’s Fund Whole-Genome Sequencing (WGS) Family Study Christoph Lange 2024-02-01 Exploring Novel Drug Candidates for Alzheimer’s Disease Through Integrative Pathway Analysis and Validation in 3D Cellular Models Doo Yeon Kim Luisa Quinti 2024-02-01 Characterization and Validation of Two Recently Created Sheep Models of Alzheimer’s Disease in Preparation for Use as a Preclinical Pharmaceutical Testing Model Russell G. Snell Natasha McKean 2024-01-31 Utility of Blood-Based Markers for Predicting Amyloid-Related Imaging Abnormalities and Their Course in Mild Cognitive Impairment and Alzheimer’s Disease Subjects Undergoing Routine Clinical Treatment with Amyloid-Directed Antibodies P. Murali Doraiswamy 2024-01-12 Growth, Characterization and Distribution of a Neurodegenerative Disease-Focused Fibroblast/iPS Cell Bank to Support Molecular Models of Patient-Specific Variation with Validation in Matched Donated Brain Tissues Derek H. Oakley 2023-12-08 Multidisciplinary Phenotyping of a Novel Humanized LOAD Mouse Model Giuseppina Tesco 2023-10-25